Literature DB >> 31469261

Multivalency Interface and g-C3N4 Coated Liquid Metal Nanoprobe Signal Amplification for Sensitive Electrogenerated Chemiluminescence Detection of Exosomes and Their Surface Proteins.

Yimeng Zhang1, Feng Wang1, Huixin Zhang1, Hongye Wang1, Yang Liu1.   

Abstract

Exosomes derived vesicles and their surface anchored proteins by cells are extremely vital in intercellular communication, immuno-stimulation, and so on, which are promising in potential tumor biomarkers for disease diagnosis. However, the highly sensitive detection of exosomes and their surface proteins is still challenging. Herein, we combined the g-C3N4 conjugated polydopamine coated Galinstan liquid metal shell-core nanohybrids (g-C3N4@Galinstan-PDA) nanoprobes and multivalent PAMAM-AuNPs electrode interface to realize a highly sensitive detection of exosomes and their surface proteins by electrogenerated chemiluminescence (ECL) biosensor. The antibody-modified PAMAM-Au nanoparticles (NPs) electrode interface provided a multivalent recognition platform for highly effective capture of exosomes. Meanwhile, the Galinstan NPs were applied as the nanoprobe. The antibody modified g-C3N4@Galinstan-PDA can recognize the exosomes specifically and exhibit stable and strong ECL signals due to the excellent features of the Galinstan NPs in facilitating electron transfer and suppressing the g-C3N4 passivation during electrochemical reduction procedures. In this way, high sensitivity for HeLa cell derived exosomes analysis was obtained with the limit of detection (LOD) of 31 particles μL-1. Moreover, we operated the exosomes analysis in the real samples including serum, urine, and blood, and identified the multiple biomarkers (GPC1, CD9, CEA, and AFP) on the exosome surface derived from different kinds of cell lines (HeLa cell, OVCAR-3 cell, and BT474 cell). These consequences suggest that the proposed ECL biosensor has the potential to be a powerful tool for exosomes study and clinical diagnostic as well as wearable devices.

Entities:  

Year:  2019        PMID: 31469261     DOI: 10.1021/acs.analchem.9b03427

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  7 in total

Review 1.  Recent advances in nanomaterial-based biosensors for the detection of exosomes.

Authors:  Linan Zhang; Chunchuan Gu; Jiajun Wen; Guangxian Liu; Hongying Liu; Lihua Li
Journal:  Anal Bioanal Chem       Date:  2020-11-08       Impact factor: 4.142

Review 2.  Branched, dendritic, and hyperbranched polymers in liquid biopsy device design.

Authors:  Michael J Poellmann; Piper Rawding; DaWon Kim; Jiyoon Bu; YoungSoo Kim; Seungpyo Hong
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2022-01-04

Review 3.  Recent Progress of Novel Electrochemiluminescence Nanoprobes and Their Analytical Applications.

Authors:  Shiyu Zhang; Yang Liu
Journal:  Front Chem       Date:  2021-02-09       Impact factor: 5.221

Review 4.  Advanced Nanotechnologies for Extracellular Vesicle-Based Liquid Biopsy.

Authors:  Li Min; Binshuai Wang; Han Bao; Xinran Li; Libo Zhao; Jingxin Meng; Shutao Wang
Journal:  Adv Sci (Weinh)       Date:  2021-08-31       Impact factor: 16.806

5.  Nanomaterials assisted exosomes isolation and analysis towards liquid biopsy.

Authors:  Xiaoni Fang; Yuqing Wang; Shurong Wang; Baohong Liu
Journal:  Mater Today Bio       Date:  2022-07-22

6.  Dancing in local space: rolling hoop orbital amplification combined with local cascade nanozyme catalytic system to achieve ultra-sensitive detection of exosomal miRNA.

Authors:  Xin Gao; Haiping Wu; Yujian Li; Lu Zhang; Mingxuan Song; Xuhuai Fu; Rui Chen; Shijia Ding; Jiawei Zeng; Jia Li; Ping Liu
Journal:  J Nanobiotechnology       Date:  2022-08-02       Impact factor: 9.429

7.  Development of a dendrimer PAMAM‑based gold biochip for rapid and sensitive detection of endogenous IFN‑γ and anti‑IFN‑γ IgG in patients with hemophagocytic lymphohistiocytosis.

Authors:  Yi-Xin Du; Lei Ye; Zi-Jian Song; Hui Lv; Qian Liu; Song-Guo Li; Sheng-Sheng Liu; Jian Hong; Yi Gao; Marion E Schneider; Wei-Dong Du
Journal:  Mol Med Rep       Date:  2020-10-16       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.